The present invention is directed to racemic 1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, racemic 1-(4-methylphenyl)-3-azabicyclo[3.1.0]hexane, and (+)-1-(4-methylphenyl)-3-azabicyclo[3.1.0]hexane, and methods of their use for treating certain nervous system disorders and conditions, including, inter alia, vasomotor symptoms (VMS) and chronic pain.
本发明涉及外消旋1-(3,4-二
氯苯基)-
3-氮杂双环[3.1.0]己烷、(+)-1-(3,4-二
氯苯基)-
3-氮杂双环[3.1.0]己烷、外消旋1-(4-甲基苯基)-
3-氮杂双环[3.1.0]己烷和(+)-1-(4-甲基苯基)-
3-氮杂双环[3.1.0]己烷,以及它们用于治疗某些神经系统障碍和病症的方法,包括血管运动症状(VMS)和慢性疼痛等。